Fibrocor Therapeutics LP

Fibrocor Therapeutics LP develops precision medicines for fibrotic diseases within the biotechnology and pharmaceutical industry. The Company advances drug candidates for conditions such as idiopathic pulmonary fibrosis and Alport Syndrome, and discovers novel therapeutics using patient-derived tissue samples. Fibrocor Therapeutics LP serves patients in the United States and Canada.